Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting.
Saved in:
| Title: | Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting. |
|---|---|
| Authors: | Saha S; Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Lund, Sweden., Gerdtham UG; Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Lund, Sweden.; Department of Economics, Lund University, Lund, Sweden., Sjödahl G; Division of Clinical and Experimental Urothelial Carcinoma Research, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Northern Registry Centre, Department of Diagnostic and Intervention, Umeå University, Umeå, Sweden., Catto JWF; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, United Kingdom., Kelly JD; Division of Surgery & Interventional Science, University College London, London, United Kingdom., Ullén A; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden., Holmberg L; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Division of Cancer Studies, Medical School, King's College London, London, United Kingdom., Liedberg F; Division of Clinical and Experimental Urothelial Carcinoma Research, Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Apr 02; Vol. 15, pp. 1556881. Date of Electronic Publication: 2025 Apr 02 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
